Cholinesterase inhibitors: new roles and therapeutic alternatives.
about
Future pharmacological treatments for substance use disordersCholinergic modulation by opioid receptor ligands: potential application to Alzheimer's diseaseExcessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activityNovel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors.Cognitive enhancement as a pharmacotherapy target for stimulant addictionAcetylcholinesterase inhibitory activity of pigment echinochrome A from sea urchin Scaphechinus mirabilis.Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening.Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.Cognitive function as an emerging treatment target for marijuana addictionThe effects of sesquiterpenes-rich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice.L-3-n-butylphthalide protects against vascular dementia via activation of the Akt kinase pathwayAccommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.Acetylcholinesterase inhibitors: pharmacology and toxicology.Modeling Alzheimer's disease in transgenic ratsStructure-based search for new inhibitors of cholinesterases.Neuroscience of behavioral and pharmacological treatments for addictionsEffects of galantamine on cocaine use in chronic cocaine usersButyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans.Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS)Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.Rg3-enriched ginseng extract ameliorates scopolamine-induced learning deficits in mice.Galantamine improves sustained attention in chronic cocaine users.T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironmentAcetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.Targeting acetylcholinesterase to treat neurodegeneration.Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairmentNeuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?Phenserine.Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents.Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus.Memantine combined with an acetyl cholinesterase inhibitor - hope for the future?The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.Cholinergic functioning in stimulant addiction: implications for medications development.Long-term effects of maternal deprivation on cholinergic system in rat brain.In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.Huprines for Alzheimer's disease drug development.
P2860
Q22242633-9E817B5E-D5EA-472B-971D-17028CC70810Q26999066-CB4C1C99-5C5B-4AE5-BFA2-8BE53F9A0F17Q28586552-0675F6F4-1834-440D-934D-AC6D8CF3B983Q33552783-E733BEEB-1357-4D99-86DB-3315833E9E71Q33599983-07D23A68-9031-4799-9C5F-D31E732A7A07Q33808974-497C5328-1791-45A6-81E1-BCDD4C6B89D7Q33890728-02D35BE6-891F-4DE2-80FC-F11F21D62980Q33919730-C21C2E0F-E20C-4C9B-B07A-2DE00186F48DQ34018386-A00B289B-BA09-4968-89CB-366F96D1FF24Q34080245-F1C0EA9F-0B5E-499D-AF93-CFFAA2D04ABDQ34094735-2F63913A-7C6D-49C2-B933-B0DC407F6BA5Q34171486-1A383708-9019-47F3-A25A-9EAD76196490Q34381860-B83C565F-8B6E-48A7-A284-653C9C816137Q34508624-A1BCA030-B0E2-47BD-94DF-11168E15C7A6Q34616235-C01A7F83-9541-4C5C-A464-B54AF8D17750Q34714494-9F987698-1D14-4AE3-8C19-57091D41FD17Q34777376-48B5FBEE-074A-4585-AF82-5162D9E4BB2DQ35009309-51DF75A4-CEEF-48FC-80DA-11B1D96D95D9Q35036163-4CA75122-AC3F-40AF-A422-06F26B830676Q35130541-111B8E89-86E3-4E4C-9DE3-336268E14F34Q35617556-58494322-5B9E-4110-9A7D-D21DF6D5FDE9Q35926454-3DA4D5FD-AFB2-4390-9DCE-EE5F930F8C82Q35953418-68B4294B-738A-43AF-A4E3-C3B3DDC13938Q36099316-1CFC1ED2-8EEB-4D22-9377-A5EA6426F7F8Q36302845-5774798D-08FC-44A0-85C6-65051AE92767Q36349629-100732D5-0C8F-4BAD-ACDF-AC2835A9B21EQ36709537-87B67AC0-29BB-410E-966C-FDBA1CCAFBFEQ36784073-D75735B6-023E-4AC6-AF9E-1EE973FFE9CDQ36817040-A635EC0A-E5D7-4DAE-BF7B-F6CCEB311F5DQ36861622-9866313E-F16A-4499-B50C-728B149E9A27Q36905746-224565C5-5751-402B-BC04-E7257EF7A5EFQ37070558-678EE0A1-208C-4E54-A95A-71F48FDF2236Q37165577-133B8B99-01E8-4C31-9031-3EEFC0B5C3DFQ37199362-0FCE7731-C989-42AC-AC6A-4360ADC2C94DQ37253578-24B66C0F-4C52-4102-BF73-6D30F364E47FQ37399395-6D9838AB-6D6E-4C62-9ACD-8CBE1A98D02AQ37618780-5F49122D-165F-422A-B039-0D0D27027D36Q37664402-E09B6F3A-51F1-490A-9C52-C2DD6A372E37Q37870701-8471BE33-B541-468F-97AD-B5F62BD7687CQ38088283-E74236A2-1B92-4AF3-B438-CFBD0B584AAE
P2860
Cholinesterase inhibitors: new roles and therapeutic alternatives.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@ast
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@en
type
label
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@ast
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@en
prefLabel
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@ast
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@en
P1476
Cholinesterase inhibitors: new roles and therapeutic alternatives.
@en
P2093
Ezio Giacobini
P304
P356
10.1016/J.PHRS.2003.11.017
P577
2004-10-01T00:00:00Z